ABCD1 Gene Adrenoleukodystrophy x-linked Genetic Test sale cost 3200 AED
DHH Gene 46XY gonadal dysgenesis partial with minifascicular neuropathy Genetic Test sale cost 4400 AED DHH Gene 46XY gonadal dysgenesis partial with minifascicular neuropathy Genetic Test Cost 5,600 د.إ Original price was: 5,600 د.إ.4,400 د.إCurrent price is: 4,400 د.إ.
ST3GAL5 Gene Amish infantile epilepsy syndrome Genetic Test sale cost 4400 AED ST3GAL5 Gene Amish infantile epilepsy syndrome Genetic Test Cost 5,600 د.إ Original price was: 5,600 د.إ.4,400 د.إCurrent price is: 4,400 د.إ.
Sale!

ABCD1 Gene Adrenoleukodystrophy x-linked Genetic Test Cost

Original price was: 5,600 د.إ.Current price is: 3,200 د.إ.

-43%

The ABCD1 Gene Adrenoleukodystrophy (ALD) X-Linked Genetic Test is a specialized diagnostic procedure aimed at detecting mutations in the ABCD1 gene, which are responsible for X-linked adrenoleukodystrophy. This genetic disorder affects the nervous system and adrenal glands, leading to a wide range of symptoms from difficulty in concentrating to severe physical disabilities. The test is particularly crucial for early detection and management of the condition, as well as for family planning purposes for those with a history of ALD. Conducted at DNA Labs UAE, a leading facility in genetic diagnostics, this test provides a comprehensive analysis of the ABCD1 gene to identify any aberrations. The cost of the test is 3200 AED, an investment towards understanding one’s genetic health and taking proactive steps in managing the condition effectively.

Home  Sample collection service available

  • 100% accuaret Test Results
  • Ranked as Most trusted Genetic DNA Lab
  • This test is not intended for medical diagnosis or treatment
Guaranteed Safe Checkout

ABCD1 Gene Adrenoleukodystrophy x-linked Genetic Test

Are you concerned about Adrenoleukodystrophy (ALD)? DNA Labs UAE offers the ABCD1 Gene Adrenoleukodystrophy x-linked Genetic Test to help diagnose this rare genetic disorder. Read on to learn more about the test and its components, cost, symptoms, diagnosis, and more.

Test Details

Adrenoleukodystrophy (ALD) is a rare genetic disorder that affects the nervous system and adrenal glands. It is caused by mutations in the ABCD1 gene, which provides instructions for making a protein that is essential for the breakdown of very long chain fatty acids (VLCFAs). When this protein is not functioning properly, VLCFAs build up in the body and cause damage to the myelin sheath that surrounds nerve cells in the brain and spinal cord.

ALD is an X-linked disorder, primarily affecting males. However, females can also be carriers of the gene mutation and may have mild symptoms or be asymptomatic.

NGS (next-generation sequencing) genetic testing is a type of genetic test that uses advanced technology to analyze multiple genes at once. This type of testing can identify mutations in the ABCD1 gene that cause ALD. NGS genetic testing for ALD may be recommended for individuals who have symptoms of the disorder, a family history of ALD, or are at risk of being carriers of the gene mutation. Testing may also be recommended for newborns as part of newborn screening programs in some states.

Early diagnosis and treatment of ALD is crucial to prevent or delay the onset of symptoms and slow the progression of the disease. Treatment options may include medications to reduce VLCFA levels, stem cell transplantation, and supportive care for symptoms such as seizures and adrenal insufficiency.

Test Name: ABCD1 Gene Adrenoleukodystrophy x-linked Genetic Test

  • Components: DNA analysis for mutations in the ABCD1 gene
  • Price: 3200.0 AED
  • Sample Condition: Blood
  • Report Delivery: 3 to 4 Weeks
  • Method: NGS Technology
  • Test Type: Neurological Disorders
  • Doctor: Neurologist
  • Test Department: Genetics

Pre Test Information

Before undergoing the ABCD1 Gene Adrenoleukodystrophy x-linked Genetic Test, it is important to provide the clinical history of the patient. Additionally, a genetic counseling session may be conducted to draw a pedigree chart of family members affected with ABCD1 Gene Adrenoleukodystrophy, x-linked.

Genetic counseling can help individuals and families understand the inheritance pattern of ALD, assess their risk of being carriers, and make informed decisions about testing and treatment options.

Don’t delay in getting the necessary genetic testing for ALD. Contact DNA Labs UAE today to schedule an appointment and take control of your health.

Test Name ABCD1 Gene Adrenoleukodystrophy x-linked Genetic Test
Components
Price 3200.0 AED
Sample Condition Blood
Report Delivery 3 to 4 Weeks
Method NGS Technology
Test type Neurological Disorders
Doctor Neurologist
Test Department: Genetics
Pre Test Information Clinical History of Patient who is going for ABCD1 Gene Adrenoleukodystrophy, x-linked NGS Genetic DNA Test A Genetic Counselling session to draw a pedigree chart of family members affected with ABCD1 Gene Adrenoleukodystrophy, x-linked
Test Details

Adrenoleukodystrophy (ALD) is a rare genetic disorder that affects the nervous system and adrenal glands. It is caused by mutations in the ABCD1 gene, which provides instructions for making a protein that is essential for the breakdown of very long chain fatty acids (VLCFAs). When this protein is not functioning properly, VLCFAs build up in the body and cause damage to the myelin sheath that surrounds nerve cells in the brain and spinal cord.

ALD is an X-linked disorder, meaning that it primarily affects males. Females can also be carriers of the gene mutation and may have mild symptoms or be asymptomatic.

NGS (next-generation sequencing) genetic testing is a type of genetic test that uses advanced technology to analyze multiple genes at once. This type of testing can identify mutations in the ABCD1 gene that cause ALD.

NGS genetic testing for ALD may be recommended for individuals who have symptoms of the disorder, a family history of ALD, or are at risk of being carriers of the gene mutation. Testing may also be recommended for newborns as part of newborn screening programs in some states.

Early diagnosis and treatment of ALD is important to prevent or delay the onset of symptoms and slow the progression of the disease. Treatment may include medications to reduce VLCFA levels, stem cell transplantation, and supportive care for symptoms such as seizures and adrenal insufficiency.

SKU: TEST-1014 Category:

Related products